share_log

Returns On Capital At Huaxia Eye Hospital GroupLtd (SZSE:301267) Have Hit The Brakes

Returns On Capital At Huaxia Eye Hospital GroupLtd (SZSE:301267) Have Hit The Brakes

華夏眼科醫院集團有限公司(深交所代碼:301267)的資本回報率已經停滯不前
Simply Wall St ·  2023/11/21 17:51

What are the early trends we should look for to identify a stock that could multiply in value over the long term? One common approach is to try and find a company with returns on capital employed (ROCE) that are increasing, in conjunction with a growing amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. With that in mind, the ROCE of Huaxia Eye Hospital GroupLtd (SZSE:301267) looks decent, right now, so lets see what the trend of returns can tell us.

我們應該尋找哪些早期趨勢來確定一隻可能長期價值成倍增長的股票?一種常見的方法是嘗試找一家公司 回報 論資本使用率(ROCE)在增加的同時增長 金額 所用資本的比例。歸根結底,這表明這是一家以不斷提高的回報率對利潤進行再投資的企業。考慮到這一點,華夏眼科醫院集團有限公司(深圳證券交易所代碼:301267)的投資回報率目前看起來不錯,所以讓我們看看回報趨勢能告訴我們什麼。

What Is Return On Capital Employed (ROCE)?

什麼是資本使用回報率(ROCE)?

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Huaxia Eye Hospital GroupLtd, this is the formula:

對於那些不知道的人來說,ROCE是衡量公司年度稅前利潤(其回報率)的指標,相對於該業務使用的資本。要計算華夏眼科醫院集團有限公司的這個指標,公式如下:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

已動用資本回報率 = 息稅前收益 (EBIT) ¥(總資產-流動負債)

0.14 = CN¥881m ÷ (CN¥7.3b - CN¥1.0b) (Based on the trailing twelve months to September 2023).

0.14 = 8.81億元人民幣 ÷(73億元人民幣-1.0億元人民幣) (基於截至2023年9月的過去十二個月)

Thus, Huaxia Eye Hospital GroupLtd has an ROCE of 14%. In absolute terms, that's a satisfactory return, but compared to the Healthcare industry average of 11% it's much better.

因此,華夏眼科醫院集團有限公司的投資回報率爲14%。從絕對值來看,這是一個令人滿意的回報,但與醫療保健行業的平均水平11%相比,回報要好得多。

View our latest analysis for Huaxia Eye Hospital GroupLtd

查看我們對華夏眼科醫院集團有限公司的最新分析

roce
SZSE:301267 Return on Capital Employed November 21st 2023
SZSE: 301267 2023 年 11 月 21 日動用資本回報率

In the above chart we have measured Huaxia Eye Hospital GroupLtd's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free report for Huaxia Eye Hospital GroupLtd.

在上圖中,我們將華夏眼科醫院集團先前的投資回報率與之前的業績進行了對比,但可以說,未來更爲重要。如果你想了解分析師對未來的預測,你應該查看我們爲華夏眼科醫院集團有限公司提供的免費報告。

What Does the ROCE Trend For Huaxia Eye Hospital GroupLtd Tell Us?

華夏眼科醫院集團有限公司的投資回報率趨勢告訴我們什麼?

The trend of ROCE doesn't stand out much, but returns on a whole are decent. The company has employed 374% more capital in the last five years, and the returns on that capital have remained stable at 14%. Since 14% is a moderate ROCE though, it's good to see a business can continue to reinvest at these decent rates of return. Over long periods of time, returns like these might not be too exciting, but with consistency they can pay off in terms of share price returns.

ROCE的趨勢並不突出,但總體回報還是不錯的。在過去五年中,該公司僱用的資本增加了374%,該資本的回報率一直穩定在14%。但是,由於14%的投資回報率適中,因此很高興看到企業能夠繼續以如此可觀的回報率進行再投資。在很長一段時間內,這樣的回報可能不會太令人興奮,但只要保持一致,它們可以在股價回報方面獲得回報。

On a side note, Huaxia Eye Hospital GroupLtd has done well to reduce current liabilities to 14% of total assets over the last five years. This can eliminate some of the risks inherent in the operations because the business has less outstanding obligations to their suppliers and or short-term creditors than they did previously.

順便說一句,華夏眼科醫院集團有限公司在過去五年中在將流動負債減少到總資產的14%方面做得很好。這可以消除運營中固有的某些風險,因爲企業對供應商和/或短期債權人的未清債務比以前少。

In Conclusion...

總之...

The main thing to remember is that Huaxia Eye Hospital GroupLtd has proven its ability to continually reinvest at respectable rates of return. And given the stock has only risen 1.7% over the last year, we'd suspect the market is beginning to recognize these trends. That's why it could be worth your time looking into this stock further to discover if it has more traits of a multi-bagger.

要記住的主要事情是,華夏眼科醫院集團有限公司已經證明了其持續以可觀的回報率進行再投資的能力。鑑於該股去年僅上漲了1.7%,我們懷疑市場已開始意識到這些趨勢。這就是爲什麼你值得花時間進一步研究這隻股票以了解它是否具有更多多袋裝的特徵。

On a final note, we've found 1 warning sign for Huaxia Eye Hospital GroupLtd that we think you should be aware of.

最後,我們發現了華夏眼科醫院集團有限公司的一個警告信號,我們認爲你應該注意這個信號。

For those who like to invest in solid companies, check out this free list of companies with solid balance sheets and high returns on equity.

對於那些喜歡投資穩健公司的人,可以查看這份資產負債表穩健和股本回報率高的公司的免費清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論